Cargando…

Identifying Educational Needs and Practice Gaps of European Hematologists and Hematology Nurses in the Treatment and Management of Multiple Myeloma

This needs-assessment aimed to identify clinical challenges faced by hematologists and hematology nurses in the diagnosis, treatment, and management of multiple myeloma, as well as contextual barriers hindering optimal care of patients with multiple myeloma. This manuscript focuses on key findings i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Suzanne, Mohty, Mohamad, Peloquin, Sophie, Van de Donk, Niels W., Leitão, Sara, Labbé, Sara, West, Sharon, Hofstädter-Thalmann, Eva, Sonneveld, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745903/ https://www.ncbi.nlm.nih.gov/pubmed/31723761 http://dx.doi.org/10.1097/HS9.0000000000000033

Ejemplares similares

Bortezomib Prescription Pattern for the Treatment of Multiple Myeloma by Hematologists in Nigeria
por: Korubo, Kaladada I., et al.
Publicado: (2017)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2020)

Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists
por: Kohno, Kei, et al.
Publicado: (2014)

P1583: EVALUATION OF THE KNOWLEDGE OF HEMATOLOGISTS ABOUT THE MANAGEMENT OF INFECTIOUS COMPLICATIONS IN HEMATOLOGIC PATIENTS
por: Guaraná, M., et al.
Publicado: (2022)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019)

Behavioral Patterns in Breaking Bad News Communication: An Ethnographic Study with Hematologists
por: Artioli, Giovanna, et al.
Publicado: (2022)

Shoulder pain: a hematologist’s perspective
por: Jain, Ankur, et al.
Publicado: (2016)

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2021)

European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
por: Bruno, Benedetto, et al.
Publicado: (2021)

Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)

Acute Mesenteric Thrombosis: A Hematologist Perspective
por: Moiz, Bushra, et al.
Publicado: (2020)

Cancer associated thrombosis: Which lessons for the hematologist?
por: Noble, Simon
Publicado: (2018)

Clinical Hematology International: Why a New Journal in Hematology?
por: Mohty, Mohamad, et al.
Publicado: (2019)

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2018)

Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center
por: Hansra, D. M., et al.
Publicado: (2018)

Universal iron fortification of foods: the view of a hematologist
por: Martins, José Murilo
Publicado: (2012)

Cancer-associated thrombosis (CAT) - New challenges for the hematologist
por: Brækkan, Sigrid
Publicado: (2018)

Introduction to a review series on COVID-19 and the hematologist
por: Ortel, Thomas L., et al.
Publicado: (2022)

Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)
por: Bahlis, Nizar J., et al.
Publicado: (2023)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
por: Bacci, Christian, et al.
Publicado: (2021)

Another Year to Celebrate Advances in Clinical Hematology
por: Mohty, Mohamad, et al.
Publicado: (2023)

The CoV-2 outbreak: how hematologists could help to fight Covid-19
por: Galimberti, Sara, et al.
Publicado: (2020)

Knowledge, Attitudes, and Practices of Hematologists Regarding Fertility Preservation in Turkey
por: Küçük, Mert, et al.
Publicado: (2013)

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective
por: Kritharis, Athena, et al.
Publicado: (2018)

Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist
por: Carreau, Nicole A., et al.
Publicado: (2019)

Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
por: Crisà, Elena, et al.
Publicado: (2021)

Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
por: Losa-Rodríguez, Rita, et al.
Publicado: (2020)

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives
por: Gay, Francesca, et al.
Publicado: (2018)

Immunotherapy for Multiple Myeloma
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Looking Ahead: Clinical Hematology International Turns One
por: Mohty, Mohamad, et al.
Publicado: (2020)

EFPIA Guideline on a Quality Framework of Principles in Lifelong Learning in Healthcare
por: Hofstädter-Thalmann, Eva, et al.
Publicado: (2022)

Mapping hematologists’ HIV testing behavior among lymphoma patients–A mixed-methods study
por: Bogers, Saskia, et al.
Publicado: (2023)

Educational needs of hematologists and laboratory professionals regarding factor activity assays
por: Adcock, Dorothy M, et al.
Publicado: (2018)

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
por: Kwaan, Hau C., et al.
Publicado: (2021)

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
por: Terpos, Evangelos, et al.
Publicado: (2020)

Management of patients with multiple myeloma during the COVID-19 pandemic
por: Malard, Florent, et al.
Publicado: (2020)

Immunotherapy in myeloma: Why, when and how?
por: van de Donk, Niels W.C.J.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jhmuocm2lq9dddvgko1jbh06nq